Document Detail


Impact of a Protocol Advocating Dexmedetomidine Over Propofol Sedation After Robotic-Assisted Direct Coronary Artery Bypass Surgery on Duration of Mechanical Ventilation and Patient Safety (April).
MedLine Citation:
PMID:  23535816     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND:Controversy remains whether propofol or dexmedetomidine is the preferred sedative following cardiac surgery. Dexmedetomidine may offer advantages over propofol among patients undergoing robotic-assisted, minimally invasive, direct coronary artery bypass (MIDCAB) surgery given the rapidity with which this population is usually extubated after surgery.OBJECTIVE:To measure the impact of a surgery protocol advocating use of dexmedetomidine rather than propofol after MIDCAB surgery on discontinuation of mechanical ventilation and patient safety.METHODS:The records on consecutive adults undergoing MIDCAB surgery who received postoperative sedation with propofol or dexmedetomidine at a 508-bed academic medical center were analyzed before and after implementation of a post-MIDCAB surgery protocol advocating dexmedetomidine use.RESULTS:Seventy-three propofol patients were compared with 53 dexmed eto midine patients. The groups were similar, except propofol patients were older (p = 0.002) and more likely to have underlying heart failure that was either moderate or severe (New York Heart Association class III or IV) (p = 0.0001). Time (median [interquartile range]) to extubation (hours) was shorter in the dexmedetomidine group (5.0 [3.6-7.0] vs 9.8 [5.0-16.3]; p = 0.0001). A Cox proportional hazards model revealed that patient age (p = 0.001) and duration of surgery (p = 0.003) influenced time to extubation between the dexmedetomidine and propofol groups but the presence of moderate or severe heart failure (p = 0.438), the number of coronary vessels operated on (p = 0.130), use of an opioid (p = 0.791), or the total dose of morphine administered (p = 0.215) did not. During sedation administration, more propofol-treated patients experienced 1 or more episodes of hypotension (systolic blood pressure =80 mmHg, 11.6% vs 0%; p = 0.02), tachycardia (heart rate =120 beats/min, 8.6% vs 0%; p = 0.04), and unarousability (Sedation Agitation Scale score =2, 30.0% vs 9.4%; p = 0.03).CONCLUSIONS:Use of a protocol promoting dexmedetomidine, rather than propofol sedation, after MIDCAB surgery facilitates faster discontinuation of mechanical ventilation and is associated with greater hemodynamic stability and arousability.
Authors:
Heather Torbic; Stella Papadopoulos; Justin Manjourides; John W Devlin
Related Documents :
23172436 - Facial dermis grafts after removal of basal cell carcinomas.
24613166 - Previous coronary stents do not increase early and long-term adverse outcomes in patien...
23379766 - Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-l...
24803156 - Ocular surface alterations in blepharospasm patients treated with botulinum toxin a inj...
17787626 - Seawater strontium isotopic variations from 2.5 million years ago to the present.
18843626 - Surgery for small asymptomatic abdominal aortic aneurysms.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-3-27
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  -     ISSN:  1542-6270     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-3-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
< Brigham and Women's Hospital, Boston, MA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute Pulmonary Emboli in a Patient on Long-Term Dabigatran Therapy (April).
Next Document:  The Rebirth of Progesterone in the Prevention of Preterm Labor (April).